Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||||
---|---|---|---|---|---|---|---|---|
Fig. 4. A-E
Pandey A et al. (2023) |
Xla Wt + adam11 MO + cnc explant + fibronectin
NF18 (immunohistochemistry) |
|
||||||
Fig. 7 B, C
Pandey A et al. (2023) |
Xla Wt + adam11 MO + cnc explant + fibronectin
NF18 (immunohistochemistry) |
|
||||||
Fig S6 D
Zhang Z et al. (2016) |
Xla Wt + fn1 MO + sdc4 MO
NF19 (in situ hybridization) |
|
||||||
Fig S6 I
Zhang Z et al. (2016) |
Xla Wt + fn1 MO + sdc4 MO
NF19 (in situ hybridization) |
|
||||||
Fig S6 K
Zhang Z et al. (2016) |
Xla Wt + fn1 MO + sdc4 MO
NF19 (in situ hybridization) |
|
||||||
fig.8.a
Kenny AP et al. (2012) |
Xla Wt + fn1 MO
NF18-20 (immunohistochemistry) |
|
||||||
fig.8.a
Kenny AP et al. (2012) |
Xla Wt + fn1 MO
NF18-20 (in situ hybridization) |
|||||||
fig.S6
Kenny AP et al. (2012) |
Xla Wt + fn1 MO
NF20 (in situ hybridization) |
|
||||||
fig.S6
Kenny AP et al. (2012) |
Xla Wt + fn1 MO
NF35/36 (in situ hybridization) |
|